Tender detail
Open-house pharmaceutical discount agreements for Pridinol (ATC M03BX03)
Summary
AOK Bayern intends to conclude non-exclusive pharmaceutical discount agreements for the active ingredient Pridinol (ATC M03BX03) with all interested pharmaceutical companies. The terms are identical for all participants and are not open to individual negotiation. The earliest start date is 1 December 2026, all agreements end on 30 November 2028, and participation is possible until 3 October 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.